Cancer Vaccine Institute News

CVI Director Dr. Nora Disis was funded $300K to advance the development of a vaccine designed to prevent ovarian cancer’s metastatic spread.

Take a look at the Cancer Vaccine Institute's 2024 Year in Review.

At the Cancer Vaccine Institute at UW Medicine (CVI), we are dedicated to ending the most common and deadly cancers through innovative...

The Kuni Foundation presented their first Wayne Kuni Award for Innovation in Cancer Research to founding director Dr. Nora Disis.

On the Cancer Research Frontier is a series spotlighting the scientists, doctors, nurses, patients, and philanthropists at the CVI.

We are excited to reveal a polished rebrand that reflects our ongoing commitment to creating a world where cancer is treated and prevented.

Dr. Shaveta Vinayak shares publicly for the first time her journey from oncologist to oncology patient. 

CVI Founding Director Dr. Nora Disis receives a grant from the Breast Cancer Research Foundation to boost the progress of a cancer vaccine.

Dr. Nora Disis visits Spokane, Washington to share the progress and promise of cancer vaccines as a prevention and cure.

CVI Founder and Director Dr. Nora Disis was named 2024 UW Medicine's Inventor of the Year for her work on cancer vaccines.

CVI Executive Director Dr. Kiran Dhillon recounts her experience of being diagnosed with breast cancer and her drive to develop a treatment.

Dr. Nora Disis, CVI Founder and Director, was featured in the Wall Street Journal to discuss the hope and proress of cancer vaccines.

An in-depth look at cancer vaccines includes CVI Director Dr. Nora Disis and patient Bridgette Hempstead.

On the Cancer Research Frontier is a series spotlighting the scientists, doctors, nurses, patients, and philanthropists at the CVI.

CVI Founding Director Dr. Nora Disis speaks on the latest innovations in cancer vaccines and how to encourage clinical trial participation.

Dr. Nora Disis and Dr. Kiran Dhillon were speakers at a national meeting organized by the U.S. Department of Health and Human Services.

The Foundation's substantial commitment to the CVI has been vital to advancing our mission to create vaccines that treat and manage cancer.

Introducing 'On the Cancer Research Frontier': a series spotlighting CVI's scientists, doctors, nurses, patients, and philanthropists.

'We all need to prioritize and make sure every woman in the room has a voice and a place at the table,' she said at her keynote address.

Congratulations to Dr. Nora Disis for being recognized as a researcher with the potential to radically improve healthcare.